Based on the national Covid-19 data recapitulation, 137 regencies/cities aggressively conducted specimen examinations exceeding the national average. Data from the week of December 11, 2022, shows a national average of 125.08 specimens per week.
The top five, starting from the highest number of specimens examined per week, are Jambi City (941 specimens), West Lampung (922 specimens), Mimika (898 specimens), Metro City (861 specimens), and Jombang (854 specimens).
Jambi City ranks first. With a population of 605,850, the number of specimens examined there is recorded at 941 per week. The latest positive rate is 3.27 percent. The positive rate in this region has decreased compared to the previous week's ratio.
Next is West Lampung. The population of this region is recorded at 309,510. In an effort to counter the Covid-19 pandemic, the number of specimens examined is 922 per week. The positive rate in this region is recorded at 1.02 percent, also down compared to the previous week's ratio.
Then, there were 898 specimens examined per week in Mimika, Metro City with a population of 174,260, recorded 861 specimens examined per week, and Jombang with 854 specimens examined per week.
To anticipate the impact of Omicron in various regions, based on the national Covid-19 data recapitulation, there are 115 regencies/cities in Indonesia that actively report the daily number of specimens examined with higher figures than before. Meanwhile, 144 other regencies/cities recorded a lower number of specimens examined compared to the previous week.
Regions outside Java with the highest number of specimens examined include Jambi City, West Lampung, and Mimika, with 941, 922, and 898 specimens examined, respectively.
Although Covid-19 transmission has decreased in some areas, the government urges everyone to continue to reduce Covid-19 transmission by always wearing masks, maintaining distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to suppressing the spread of the coronavirus.